Harvard Bioscience (HBIO) EBITDA Margin (QoQ) (2010 - 2026)
Harvard Bioscience (HBIO) EBITDA Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.42 Bn | 129.21 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.47 Bn | 51.60 Bn | 2.32 Bn |
| 3 | Alcon | 35.75 Bn | 34.40 Bn | 1.68 Bn |
| 4 | Resmed | 33.73 Bn | 32.26 Bn | 861.22 Mn |
| 5 | Medline | 29.13 Bn | 26.45 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.02 Bn | 24.58 Bn | 329.20 Mn |
| 7 | Solventum | 15.40 Bn | 14.99 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.81 Bn | 14.67 Bn | 735.40 Mn |
| 9 | Baxter International | 13.62 Bn | 11.47 Bn | 1.03 Bn |
| 10 | Harvard Bioscience | 33.90 Mn | 27.40 Mn | 12.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 135.00 |
| Mar 31, 2026 | -1,286.00 |
| Dec 31, 2025 | 625.00 |
| Sep 30, 2025 | 496.00 |
| Jun 30, 2025 | 22,410.00 |
| Mar 31, 2025 | -22,815.00 |
| Dec 31, 2024 | 857.00 |
| Sep 30, 2024 | 43.00 |
| Jun 30, 2024 | 34.00 |
| Mar 31, 2024 | -1,030.00 |
| Dec 31, 2023 | 468.00 |
| Sep 30, 2023 | -645.00 |
| Jun 30, 2023 | -307.00 |
| Mar 31, 2023 | 744.00 |
| Dec 31, 2022 | 1,237.00 |
| Sep 30, 2022 | -2,766.00 |
| Jun 30, 2022 | 3,701.00 |
| Mar 31, 2022 | -2,846.00 |
| Dec 31, 2021 | 329.00 |
| Sep 30, 2021 | 165.00 |